ClinicalTrials.Veeva

Menu

An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths

M

Mondelez International

Status

Terminated

Conditions

Helminthiasis

Treatments

Other: Control Food Product
Other: Novel Food Product

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT01271049
ABS-00-02

Details and patient eligibility

About

The prevalence of intestinal helminths is worldwide. This study will evaluate the tolerability of a novel food product consumed by adults residing in an area endemic for helminths.

Enrollment

45 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy Male or Female adults, age 18-45 years old inclusive on date of screening
  • Showing presence of no or mild-moderate helminths

Exclusion criteria

  • Presence of heavy helminth load
  • Pregnant or lactating
  • Hepatosplenomegaly or clinically significant abnormal hemoglobin, LAT or creatinine

Trial design

45 participants in 2 patient groups, including a placebo group

Control Food Product
Placebo Comparator group
Description:
Consumption of placebo food product
Treatment:
Other: Control Food Product
Novel Food Product
Experimental group
Description:
Consumption of novel food product
Treatment:
Other: Novel Food Product

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems